Literature DB >> 14574563

Nematocidal activity of nitazoxanide in laboratory models.

F Fonseca-Salamanca1, M M Martínez-Grueiro, A R Martínez-Fernández.   

Abstract

The nematocidal activity of a broad-spectrum antiparasitic agent, nitazoxanide [( N-(5-nitrothiazol-2-gammal)salicylamide; NTZ], was evaluated in both in vitro and in vivo models using Caenorhabditis elegans, Heligmosomoides polygyrus and Trichinella spiralis. In vitro, NTZ (100 muM) exhibited a low activity against C. elegans and had no effect on embryonation and hatching of H. polygyrus eggs. At concentrations of 100 and 50 muM, the inhibition of excretion/secretion of acetylcholinesterase and acid phosphatase of adult H. polygyrus by NTZ was variable. The in vitro effects of mebendazole (5 muM), albendazole (1 muM) and levamisole (10 muM) were superior to those of NTZ. In mice, NTZ at 1 g/kg proved to be inactive against preadults of T. spiralis whereas mebendazole at 10 mg/kg reduced the worm burden by up to 83%. NTZ at 1 g/kg per day for 3 consecutive days showed a low activity against adults of H. polygyrus (21% reduction). Levamisole, at a single dose of 10 mg/kg, reduced the worm burden by up to 89.9%. The results of this study suggest that NTZ would not have met criteria of a candidate compound.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574563     DOI: 10.1007/s00436-003-0974-7

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  12 in total

1.  Treatment of intestinal parasitic infections: a review of nitazoxanide.

Authors:  Herbert M Gilles; Paul S Hoffman
Journal:  Trends Parasitol       Date:  2002-03

2.  Acid phosphatase activity in excretion/secretion products from Heligmosomoides polygyrus adults: an indicator of the physiological status of the worms.

Authors:  M M Martínez-Grueiro
Journal:  Parasitol Res       Date:  2002-06-14       Impact factor: 2.289

3.  Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico.

Authors:  R Romero Cabello; L R Guerrero; M R Muñóz García; A Geyne Cruz
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

4.  Acetylcholinesterase secretion--a parameter for the interpretation of in vitro anthelmintic screens.

Authors:  E B Rapson; A S Chilwan; D C Jenkins
Journal:  Parasitology       Date:  1986-04       Impact factor: 3.234

5.  Studies with methyridine and Trichinella spiralis. 2. The use of the drug to study the rate of larval production in mice.

Authors:  D A Denham; A R Martinez
Journal:  J Helminthol       Date:  1970       Impact factor: 2.170

6.  Improved detection of anthelmintic activity in an in vitro screen utilizing adult Nippostrongylus brasiliensis.

Authors:  E B Rapson; D C Jenkins; A S Chilwan
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

7.  The in vitro secretion of acetylcholinesterase by adult stages of Heligmosomoides polygyrus: the effects of broad-spectrum anthelmintics.

Authors:  P Alonso-Villalobos; M M Martinez-Grueiro
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2000-02

8.  Haemonchus contortus (Nematoda: Trichostrongylidae) is much more sensitive than Caenorhabditis elegans (Nematoda: Rhabditidae) to the ovicidal action of thiabendazole.

Authors:  A Fasiuddin; W C Campbell
Journal:  J Parasitol       Date:  2000-06       Impact factor: 1.276

9.  Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children.

Authors:  Cesar E Davila-Gutierrez; Clemente Vasquez; Benjamin Trujillo-Hernandez; Miguel Huerta
Journal:  Am J Trop Med Hyg       Date:  2002-03       Impact factor: 2.345

10.  Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru.

Authors:  Jave Ortiz Juan; Nicholas Lopez Chegne; Gilles Gargala; Loic Favennec
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Mar-Apr       Impact factor: 2.184

View more
  8 in total

1.  Nitazoxanide: nematicidal mode of action and drug combination studies.

Authors:  Vishal S Somvanshi; Brian L Ellis; Yan Hu; Raffi V Aroian
Journal:  Mol Biochem Parasitol       Date:  2014-01-08       Impact factor: 1.759

2.  Synthesis, biological evaluation, and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania.

Authors:  Jozef Stec; Qingqing Huang; Marco Pieroni; Marcel Kaiser; Alina Fomovska; Ernest Mui; William H Witola; Samuel Bettis; Rima McLeod; Reto Brun; Alan P Kozikowski
Journal:  J Med Chem       Date:  2012-03-20       Impact factor: 7.446

3.  Bacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in mice.

Authors:  Yan Hu; Sophia B Georghiou; Alan J Kelleher; Raffi V Aroian
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

Review 4.  Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.

Authors:  Vanessa R Anderson; Monique P Curran
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Bacterial pore-forming proteins as anthelmintics.

Authors:  Yan Hu; Raffi V Aroian
Journal:  Invert Neurosci       Date:  2012-05-05

6.  Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination.

Authors:  Lucienne Tritten; Angelika Silbereisen; Jennifer Keiser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-03-10       Impact factor: 4.077

7.  EFFICACY OF NITAZOXANIDE AGAINST Toxocara canis: LARVAL RECOVERY AND HUMORAL IMMUNE RESPONSE IN EXPERIMENTALLY INFECTED MICE.

Authors:  Susana A Zevallos Lescano; Sergio Vieira dos Santos; Jesiel Maurício Lemos Assis; Pedro Paulo Chieffi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

Review 8.  Drug discovery: Insights from the invertebrate Caenorhabditis elegans.

Authors:  Sebastián Giunti; Natalia Andersen; Diego Rayes; María José De Rosa
Journal:  Pharmacol Res Perspect       Date:  2021-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.